Antipsychotics and antidepressants: An analysis of cost growth in finland from 1999 to 2005
Authors:
- Hanna KoskinenHKHanna Koskinen
- Jaana E. MartikainenJMJaana E. Martikainen
- Timo MaljanenTMTimo Maljanen
- 1 January 2009
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 31, 1469-1477
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?International Clinical Psychopharmacology, 2008
- Who Are the New Users of Antipsychotic Medications?Psychiatric Services, 2008
- The Evolution of Drug Development in Schizophrenia: Past Issues and Future OpportunitiesNeuropsychopharmacology, 2007
- Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticalsHealth Policy, 2007
- Reasons for antidepressant prescriptions in CanadaPharmacoepidemiology and Drug Safety, 2007
- Interventions to improve antibiotic prescribing practices in ambulatory careCochrane Database of Systematic Reviews, 2005
- Changes in drug utilization following the outpatient prescription drug cost-sharing program—evidence from Taiwan’s elderlyHealth Policy, 2004
- Why Did Drug Spending Increase During the 1990s?PharmacoEconomics, 2004
- National Trends in the Use of Outpatient PsychotherapyAmerican Journal of Psychiatry, 2002
- Explaining Drug Spending Trends: Does Perception Match Reality?Health Affairs, 2000